An open labelled controlled clinical study to evaluate the efficacy of kukkutanda basti in hypoalbuminemia in childhood minimal changes nephrotic syndrome. - nil

Parul Ayurved Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年7月25日

试验速览

暂无简介。

•Age group- 3 to 10 years
•Diagnosed cases of primary type of nephrotic syndrome (idiopathic) of either the
•The other alternate modern treatment to be continued as per recommended dose
•according to allopathy treatment protocol as per the guideline
•Children with parents who agree to participate and sign informed consent

•Patients of nephrotic syndrome due to other disorders i.e SLE, drug toxicity, any
•genetic disorders.
•Patients of nephrotic syndrome associated with illness like cardiovascular disease, tuberculosis, immuno deficiency syndrome, etc.
•Advanced or critical phase of nephrotic syndrome which requires immediate intervention like dialysis depending on history and general condition at the point of examination as found by the investigator will be excluded from the study.

发起方

Parul Ayurved Hospital